Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 138572

Novel OCTN2 mutations: no genotype-phenotype correlations: early carnitine therapy prevents cardiomyopathy


Lamhonwah, Anne-Marie; Olpin, Simon E.; Pollitt, Rodney J.; Vianey-Saban, Christine; Divry, Priscille; Guffon, Nathalie; Besley, Guy T.; Onizuka, Rusell; De Meirleir, Linda J.; Cvitanović-Sojat, Ljerka et al.
Novel OCTN2 mutations: no genotype-phenotype correlations: early carnitine therapy prevents cardiomyopathy // American Journal of Medical Genetics, 111 (2002), 3; 271-84 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 138572 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Novel OCTN2 mutations: no genotype-phenotype correlations: early carnitine therapy prevents cardiomyopathy

Autori
Lamhonwah, Anne-Marie ; Olpin, Simon E. ; Pollitt, Rodney J. ; Vianey-Saban, Christine ; Divry, Priscille ; Guffon, Nathalie ; Besley, Guy T. ; Onizuka, Rusell ; De Meirleir, Linda J. ; Cvitanović-Sojat, Ljerka ; Barić, Ivo ; Dionisi-Vici, Carlo ; Fumić, Ksenija ; Maradin, Miljenka ; Tein, Ingrid

Izvornik
American Journal of Medical Genetics (0148-7299) 111 (2002), 3; 271-84

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
OCTN2 mutacije; genotip-fenotip; terapija karnitinom; kardiomiopatija
(OCTN2 mutations; genotype-phenotype; carnitine therapy; cardiomyopathy)

Sažetak
Primary systemic carnitine deficiency or carnitine uptake defect (OMIM 212140) is a potentially lethal, autosomal recessive disorder characterized by progressive infantile-onset cardiomyopathy, weakness, and recurrent hypoglycemic hypoketotic encephalopathy, which is highly responsive to L-carnitine therapy. Molecular analysis of the SLC22A5 (OCTN2) gene, encoding the high-affinity carnitine transporter, was done in 11 affected individuals by direct nucleotide sequencing of polymerase chain reaction products from all 10 exons. Carnitine uptake (at Km of 5 microM) in cultured skin fibroblasts ranged from 1% to 20% of normal controls. Eleven mutations (delF23, N32S, and one 11-bp duplication in exon 1 ; R169W in exon 3 ; a donor splice mutation [IVS3+1 G > A] in intron 3 ; frameshift mutations in exons 5 and 6 ; Y401X in exon 7 ; T440M, T468R and S470F in exon 8) are described. There was no correlation between residual uptake and severity of clinical presentation, suggesting that the wide phenotypic variability is likely related to exogenous stressors exacerbating carnitine deficiency. Most importantly, strict compliance with carnitine from birth appears to prevent the phenotype

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti, Dentalna medicina



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Zagreb


Citiraj ovu publikaciju:

Lamhonwah, Anne-Marie; Olpin, Simon E.; Pollitt, Rodney J.; Vianey-Saban, Christine; Divry, Priscille; Guffon, Nathalie; Besley, Guy T.; Onizuka, Rusell; De Meirleir, Linda J.; Cvitanović-Sojat, Ljerka et al.
Novel OCTN2 mutations: no genotype-phenotype correlations: early carnitine therapy prevents cardiomyopathy // American Journal of Medical Genetics, 111 (2002), 3; 271-84 (međunarodna recenzija, članak, znanstveni)
Lamhonwah, A., Olpin, S., Pollitt, R., Vianey-Saban, C., Divry, P., Guffon, N., Besley, G., Onizuka, R., De Meirleir, L. & Cvitanović-Sojat, L. (2002) Novel OCTN2 mutations: no genotype-phenotype correlations: early carnitine therapy prevents cardiomyopathy. American Journal of Medical Genetics, 111 (3), 271-84.
@article{article, author = {Lamhonwah, Anne-Marie and Olpin, Simon E. and Pollitt, Rodney J. and Vianey-Saban, Christine and Divry, Priscille and Guffon, Nathalie and Besley, Guy T. and Onizuka, Rusell and De Meirleir, Linda J. and Cvitanovi\'{c}-Sojat, Ljerka and Bari\'{c}, Ivo and Dionisi-Vici, Carlo and Fumi\'{c}, Ksenija and Maradin, Miljenka and Tein, Ingrid}, year = {2002}, pages = {271-84}, keywords = {OCTN2 mutacije, genotip-fenotip, terapija karnitinom, kardiomiopatija}, journal = {American Journal of Medical Genetics}, volume = {111}, number = {3}, issn = {0148-7299}, title = {Novel OCTN2 mutations: no genotype-phenotype correlations: early carnitine therapy prevents cardiomyopathy}, keyword = {OCTN2 mutacije, genotip-fenotip, terapija karnitinom, kardiomiopatija} }
@article{article, author = {Lamhonwah, Anne-Marie and Olpin, Simon E. and Pollitt, Rodney J. and Vianey-Saban, Christine and Divry, Priscille and Guffon, Nathalie and Besley, Guy T. and Onizuka, Rusell and De Meirleir, Linda J. and Cvitanovi\'{c}-Sojat, Ljerka and Bari\'{c}, Ivo and Dionisi-Vici, Carlo and Fumi\'{c}, Ksenija and Maradin, Miljenka and Tein, Ingrid}, year = {2002}, pages = {271-84}, keywords = {OCTN2 mutations, genotype-phenotype, carnitine therapy, cardiomyopathy}, journal = {American Journal of Medical Genetics}, volume = {111}, number = {3}, issn = {0148-7299}, title = {Novel OCTN2 mutations: no genotype-phenotype correlations: early carnitine therapy prevents cardiomyopathy}, keyword = {OCTN2 mutations, genotype-phenotype, carnitine therapy, cardiomyopathy} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font